Irritable Bowel Syndrome Trial, Recruiting NCT06866106 Sponsor: Massachusetts General Hospital Condition: Irritable Bowel Syndrome
Back to Irritable Bowel Syndrome

Irritable Bowel Syndrome Trial, Recruiting

NCT06866106
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults who have been diagnosed with Irritable Bowel Syndrome (IBS) that meets a standard set of diagnostic guidelines called the Rome IV criteria.
  • People who are fluent in English and have access to a phone.

Who may not be able to join:

  • People who have inflammatory bowel disease or another gut condition that could better explain their IBS-like symptoms, based on what the patient or their doctor has reported or what is noted in their medical records.
  • People who are currently experiencing a manic episode, psychosis, or an active substance use disorder, as determined through specific structured psychiatric interviews used in the study.
  • People who have significant difficulties with memory or thinking, as assessed by a brief cognitive screening tool used for research purposes.
  • People who have atrial fibrillation (an irregular heart rhythm), a cardiac pacemaker, or who take beta-blocker medications every day, based on patient report or medical records.
  • People who are planning to start or take part in another new mental health or behavioural therapy program during the study period.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Elizabeth N Madva, MD, Massachusetts General Hospital

Phone: 617-724-6300

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
30 October 2025
Est. completion
1 April 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Proportion of Intervention Sessions Completed by Participants; Ease of Weekly Exercises; Utility of Weekly Exercises

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov